ABCELLERA BIOLOGICS INC's ticker is ABCL and the CUSIP is 00288U106. A total of 201 filers reported holding ABCELLERA BIOLOGICS INC in Q4 2022. The put-call ratio across all filers is 0.52 and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $14,475 | -31.6% | 3,146,833 | -3.9% | 0.02% | -23.1% |
| Q2 2023 | $21,158 | -13.5% | 3,275,301 | +1.0% | 0.03% | -18.8% |
| Q1 2023 | $24,453 | -16.9% | 3,243,199 | +11.6% | 0.03% | -22.0% |
| Q4 2022 | $29,439 | -99.9% | 2,906,212 | -11.5% | 0.04% | -12.8% |
| Q3 2022 | $32,488,000 | -8.8% | 3,285,022 | -1.8% | 0.05% | -2.1% |
| Q2 2022 | $35,640,000 | +14.6% | 3,346,497 | +4.9% | 0.05% | +33.3% |
| Q1 2022 | $31,100,000 | +648.1% | 3,189,837 | +997.1% | 0.04% | +800.0% |
| Q4 2021 | $4,157,000 | +47.2% | 290,746 | +106.2% | 0.00% | +33.3% |
| Q3 2021 | $2,825,000 | – | 141,008 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Founders Fund VII Management, LLC | 3,773,530 | $75,584,000 | 86.10% |
| Gruss & Co., LLC | 430,407 | $8,625,000 | 24.12% |
| SB Management Ltd | 9,817,190 | $196,736,000 | 20.16% |
| GUARDIAN CAPITAL ADVISORS LP | 3,836,414 | $76,767,000 | 7.97% |
| Intellectus Partners, LLC | 1,223,429 | $24,518,000 | 5.93% |
| HARVARD MANAGEMENT CO INC | 4,105,095 | $82,266,000 | 4.82% |
| ArchPoint Investors | 461,289 | $9,244,000 | 2.77% |
| Belmont Capital, LLC | 150,000 | $3,006,000 | 2.44% |
| CLOUGH CAPITAL PARTNERS L P | 971,297 | $19,465,000 | 1.18% |
| Orbimed Advisors | 4,180,768 | $83,783,000 | 0.92% |